These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
What is Tesamorelin?
Key Research
Specifications
Property | Details |
---|---|
CAS Number | 218949-48-5 |
Chemical Name | Synthetic GHRH analog, 44 amino acids with N-terminal modification |
PubChem CID | 16137828 |
Molecular Formula | C221H366N72O67S |
Molecular Weight | ≈ 5135.9 g/mol |
Physical Appearance | White to off-white lyophilized powder |
Form | Synthetic GHRH analogue (44 aa polypeptide, N-terminal stabilized) |
Container | 3 mL glass vial (5 mg net content) |
Purity | ≥99% verified by HPLC & MS (batch COA via on-vial QR) |
Solubility | Soluble in sterile water or compatible buffer; gently invert until dissolved; filter-sterilize if needed |
Intended Use | Laboratory research only (RUO). Not for human or animal use. |
Molecular Structure

FAQ
How much is in each vial?
Does it come with instructions?
What other supplies are needed?
How long does a vial last?
Which in-vitro or experimental assays is Tesamorelin commonly used in?
References
- Falutz, J., et al. “Metabolic effects of a growth hormone–releasing factor in patients with HIV.” New England Journal of Medicine 357(23), 2007, 2359–2370. [Link]
- Falutz, J., et al. “Long-term safety and effects of tesamorelin, a growth hormone–releasing factor analogue, in HIV patients with abdominal fat accumulation.” AIDS 22(14), 2008, 1719–1728. [Link]
- Allas, S., et al. “Safety and efficacy of tesamorelin, a growth hormone–releasing factor analogue, in HIV-infected patients with abdominal fat accumulation: pooled analysis of two multicenter trials.” Journal of Clinical Endocrinology & Metabolism 97(9), 2012, 3493–3502. [Link]
- Guaraldi, G., et al. “Efficacy and safety of tesamorelin in the treatment of abdominal fat accumulation in HIV-infected patients.” Current HIV Research 11(6), 2013, 537–549. [Link]
- Erlandson, K. M., et al. “Effects of tesamorelin on liver fat and visceral adipose tissue in HIV-infected adults with nonalcoholic fatty liver disease.” Journal of Clinical Endocrinology & Metabolism 104(12), 2019, 5641–5653. [Link]
Why Buy from USA Peptides Direct
- USA Made
- Same-Day Shipping (Mon–Fri, on in-stock items)
- GMP-Standard lyophilization, documented & traceable
- 24/7 Support
- Price Match Guarantee
- Batch Tracking with QR Code Verification
- 3rd-Party U.S. Lab Testing — purity, quantity, endotoxin
- Cold-Chain Shipping — Always (no paid upgrade)
- All Major Payments Accepted
- Text & Email Order Updates
- 2-Day FedEx/UPS Shipping Standard
- Cheapest Overnight Rates
- Large Variety of Peptides & Bioregulators
Quality, Storage & Handling
Each lot is confirmed by HPLC (purity) and MS (identity); QR on the vial links to the batch COA. Independent U.S. labs verify purity, quantity, and endotoxin.
- Storage (lyophilized): −20 °C long-term or 2–8 °C short-term; keep desiccated and protected from light.
- After reconstitution: Use neutral, oxygen-poor buffer when possible; aliquot and store at ≤−20 °C; avoid repeated freeze–thaw.
- Working solutions: Prepare fresh; minimize exposure to light/alkaline pH to reduce degradation.
Shipping
Ships in validated cold-chain packaging. In-stock orders placed before the daily cutoff dispatch the same day. 2-Day FedEx/UPS is standard, with overnight options available. Automated text/email updates included.
Compliance & Research Use Only Disclaimer
For laboratory research only. All articles are product information provided on this website are for informational and educational purposes only. Not a drug, cosmetic, food, or household chemical. Not for human or animal use, diagnostic, or therapeutic applications. Buyers warrant they are qualified to handle RUO materials under applicable laws and institutional guidelines. COAs available via QR or upon request.